semaglutide vs tirzepatide vs liraglutide vs. Semaglutide: What You Should Know Tirzepatide more effective than semaglutide

Orforglipron (branded as Foundayo) is the first small molecule GLP-1 receptor agonist, distinguishing it from peptide-based options like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound)

This results in a lower ability to promote receptor internalization compared with endogenous GLP-1, so it allows to have an increased GLP-1R expression on the cell surface, which translates in more robust insulinotropic properties, possibly explaining the enhanced insulin secretion (in both diabetic and not diabetic human islets), induced by TZP (19) by approximately 25% more than the one induced by only one of the two agents

GLP-1 receptor agonists such as semaglutide and liraglutide have shown reductions in ApoB, ApoC3, NT-proBNP, and IL-6 levels

It also helps determine whether your body burns muscle, carbohydrates, or fat for energyprioritizing fat utilization leads to better body composition